Takeaway

• Nice confirmatory data were presented supporting clinical practice decisions.
• An active search for biomarkers is ongoing, to refine patient selection and make adequate therapeutic decisions.

Tackling the hard challenge to pack all the results from the early breast cancer (eBC) track in a 20-minute presentation, Ana Bosh, Skåne...